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A GM 1 ganglioside derivative bearing a photoreactive nitrophenyl azide group and tritium labeled at the acetyl group of N-acetylneuraminic acid, 
has been administered to cultured human fibroblasts. With photolabeling experiments we found that a portion of the ganglioside in the cell cytosol 
was associated with a soluble protein of about 30 kDa. 
Photoreactive GM 1; Cytosolic omplex; Ganglioside-protein interaction 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Gangliosides are normal constituents of the external 
layer of the plasma membranes of vertebrate cells [1]. 
Although the main site of ganglioside deposition is the 
plasma membrane, small amounts of gangliosides oc- 
cur in soluble form in the brain of different animals 
and in cultured cells [2-7]. In calf [3] and rat [6] brain 
cytosolic gangliosides were shown to be present as 
lipoprotein complexes having varying ganglioside and 
protein composition. A role for ganglioside-protein 
complexes as intracellular 'carriers' to and from the 
plasma membrane or between different intracellular 
membranes has been suggested [2,5,6]. 
Addition of gangliosides to the culture medium leads 
to their insertion into the plasma membrane of cells 
[8,10-13] followed by penetration i to the cell interior. 
When we exposed cultured human fibroblasts to a 
radioactive derivative of GM1 ganglioside bearing a 
photoreactive group in the lipid moiety [13], we observ- 
ed that the uptake of ganglioside molecules by the cells 
was mediated by specific membrane proteins. In the 
present work we administered the same derivative of 
GM1 to cultured human fibroblasts and showed that a 
portion of the administered ganglioside reached the 
cytosol where it was associated with a soluble protein 
of about 30 kDa. 
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2.1. Reagents 
Commercial chemicals were the purest available. Trypsin and 
Neu5Ac were from Sigma. Vibrio cholerae sialidase was from Behr- 
ingwerke. All the solutions for fibroblast cultures and washing were 
from Flow Laboratories. GM1 ganglioside, II3Neu5AcGgOse4Cer,/5'- 
Gal-( 1--3 )-~-GalNAc-(l--4)-[oe-Neu5Ac-(2--3)] ~'-Gal-(1--4)-fl-Glc- 
(1--1)-Cer, was extracted from pig brain [15], purified over 99% and 
characterized [16]. [3H]GMI(N3), fl-Gal-(1--3)-~'-GalNAc-(1--4)-lcr- 
Neu5[aH]Ac-(2--3) ]-fl-Gal-(l--4)-fl-Glc-(1--1)- { 2-[12-(2-nitro-4-azid- 
ophenyl)amino-dodecanoyl]-amino-3-hydroxy-octadec/eicos-4t-ene I 
(4.2 Ci/mmol), was prepared from GM1 [13]. Human fibroblast cells 
were prepared and maintained in culture as reported [13]. 
2.2. Treatment offibroblasts wRh fH]GMl(?43) and preparation of 
the fibroblast cytosolic fraction 
[3H]GMI(N3) and GM1 in a molar ratio of 1 : 10 were dissolved in 
an appropriate volume of Eagle's minimum essential medium with 
Earle's alts (EMEM) to obtain a final 10 -4 M ganglioside concentra- 
tion. Cells were incubated at 37°C in 2 ml of the ganglioside- 
containing medium for up to 24 h, and then washed and treated as 
reported [9,10,13]. All the above-described operations were carried 
out in the dark. 
After UV illumination (360 nm) for 40 min, the cells were pelleted 
and homogenized in 200/A of 0.25 M sucrose containing 0.1 mM 
bisodium EDTA and 1 mM potassium phosphate buffer [16]. The 
suspension was then centrifuged at 150000 × g for 1 h at 4°C. The 
upper third of the supernatant (cytosolic fraction) was accurately 
siphoned, the remaining supernatant being disregarded. The collected 
supernatant was dialyzed, frozen, and lyophilized. The lyophilized 
material was suspended (1 mg/ml) in 0.01 N potassium-phosphate 
buffer, pH 7.0, and lipids not covalently linked to the proteins [13] 
were extracted [14]. An aliquot of the delipidized residue was submit- 
ted to liquid scintillation counting, a second aliquot was analyzed by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) [13]. In preliminary experiments he delipidized pellet was 
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subjected to Vibrio cholerae sialidase treatment to determine the 
protein-bound radioactive sialic acid. 
In further experiments the GM1 derivative was incubated irectly 
with the cytosolic fraction of the fibroblast cell prepared as above 
and the incubation mixture, after illumination, was treated as 
reported for radioactive protein analyses. 
2.3. Colorimetric methods 
GM1 ganglioside was assayed as bound Neu5Ac by the resorcinol- 
HCI method [17,18], pure Neu5Ac being used as the reference stan- 
dard. The protein content was determined in solubilized pellets and 
cytosolic fraction [19,20], with bovine serum albumin as standard. 
3. RESULTS AND DISCUSSION 
The use of  photoreactive ganglioside [3H]GMI(N3) 
demonstrated that gangliosides, after binding to sur- 
face membrane proteins, entered the cell interior and 
generated metabolic products, thus giving rise to a large 
number of  labeled proteins [13]. The aim of this work 
was to test if [3H]GMI(N3) is present in the cell cytosol 
and is able to bind to cytosolic proteins. 
The time course of  radioactivity incorporation in the 
soluble fraction obtained from fibroblasts during in- 
cubation with [3H]GMI(N3) and GM1 is presented in 
Fig. 1. A measurable amount of  radioactivity was 
already present in the cytosol after one hour of  incuba- 
tion. It increased with time, reaching a value of  
720000 dpm/mg cytosolic proteins after 24 h, and at 
all incubation times the radioactivity carried by the 
cytosolic fraction was about 4°7o of  the total radioac- 
tivity incorporated by the ceils. Extraction of  free lipids 
f rom cytosol diminished the radioactivity content, and 
the protein-bound radioactivity was about 
42000 dpm/mg after 24 h (see Fig. 1). Sialidase treat- 
ment of the cytosolic proteins led to the release of  
3-4°70, for the 24 h incubation, of the total radioactivi- 
ty, indicating that under the experimental conditions, 
recycling of  sialic acid for cytosolic glycoprotein 
biosynthesis occurred to a very low extent, and that the 
radioactivity carried by the proteins is derived from the 
covalently linked ganglioside. 
The SDS-PAGE analysis of  cell cytosol after 24 h in- 
cubation of  cells with ganglioside followed by illumina- 
tion is presented in Fig. 2. The profile obtained by the 
Coomassie blue staining procedure is compared with 
that obtained by f luorography. Few of  the proteins pre- 
sent in the cytosol were labeled by the ganglioside and 
one in particular carried about 70°70 of the total 
protein-bound radioactivity. This protein corresponds 
to a band which shows a molecular weight of about 
30 kDa. A band carrying a large amount of  radioactivi- 
ty and corresponding to lipid material is present at the 
lower edge of the SDS-PAGE.  The observation that on- 
ly a small number of  cytosolic proteins became labeled 
indicates that the binding of  gangliosides to cytosolic 
proteins might be a rather specific process and supports 
a previous suggestion indicating the occurrence of 
specific ganglioside-protein complexes in the cytosol 
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Fig. 1. Time course of the radioactivity incorporation i to the cytosol 
of human fibroblast cells, after cell incubation with the mixture GM 1 
and [3H]GMI(N3). Solid line, total incorporated radioactivity; 
broken line, radioactivity linked to proteins. 
[6]. This was reinforced by further experiments in 
which the cytosolic fraction of  fibroblasts was in- 
cubated with GM1 and [3H]GMI(N3) for 2 h. The 
f luorographic SDS-PAGE protein profile (gangliosides 
were extracted before protein analyses) is presented in 
Fig. 2. In this experiment the quantity of  GM1 linked 
to proteins was higher, although the ganglioside- 
protein interactions differ f rom those occurring using 
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Fig. 2. SDS-PAGE separation of human fibroblast cytosolic proteins. 
(Lane 1) Cytosol of cultured fibroblasts after 24 h incubation of the 
cells with the mixture GMI and [3H]GMI(N3), 4.3,ug of proteins, 
3100 dpm, autoradiographic detection; (lane 2) protein pattern after 
2 h of incubation of GM1 and [3H]GMI(N3) with the cytosol of 
cultured fibroblasts and lipid extraction, 5/~g of proteins, 5500 dpm, 
autoradiographic detection; (lane 3) protein pattern of the cytosol of 
cultured fibroblasts, 15/zg of proteins, Coomassie blue staining; (lane 
4) mixture of standard proteins, 20000 dpm, autoradiographic 
detection. 
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intact  cells. On ly  a smal l  number  o f  bands is present;  
one band showing a mo lecu la r  weight  o f  about  30 kDa 
is still ev ident  and is a ma jor  component  o f  the radioac-  
t ive prote in  pattern.  
Character i za t ion  o f  the soluble 30 kDa prote in  and 
ver i f i cat ion  o f  its funct iona l  impl icat ions  require fur- 
ther study. 
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